Company Data

Cingulate Inc.

Ticker
CING
Current Price
$4.23 -2.08%
Market Cap
$13.6M
Price Target
Refer to Report
Volume
111.2K
52wk Range
$1.8001 - $20.83
Advanced Market Data

Overview

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy